Uniting Wealth Partners LLC purchased a new stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,375 shares of the company’s stock, valued at approximately $231,000.
A number of other hedge funds also recently added to or reduced their stakes in PG. NewSquare Capital LLC raised its stake in shares of Procter & Gamble by 933.3% in the fourth quarter. NewSquare Capital LLC now owns 155 shares of the company’s stock worth $26,000 after purchasing an additional 140 shares during the last quarter. Hoey Investments Inc. raised its position in Procter & Gamble by 321.7% in the 4th quarter. Hoey Investments Inc. now owns 194 shares of the company’s stock worth $33,000 after buying an additional 148 shares during the last quarter. LFA Lugano Financial Advisors SA bought a new position in Procter & Gamble during the 4th quarter valued at about $34,000. Atlantic Private Wealth LLC boosted its holdings in shares of Procter & Gamble by 95.3% during the 4th quarter. Atlantic Private Wealth LLC now owns 207 shares of the company’s stock valued at $35,000 after acquiring an additional 101 shares during the last quarter. Finally, Prudent Man Investment Management Inc. bought a new stake in shares of Procter & Gamble in the fourth quarter worth approximately $38,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
PG has been the topic of several research reports. Piper Sandler dropped their target price on shares of Procter & Gamble from $173.00 to $172.00 and set a “neutral” rating on the stock in a report on Monday, February 24th. Wells Fargo & Company upped their price objective on Procter & Gamble from $176.00 to $180.00 and gave the company an “overweight” rating in a research report on Thursday, January 23rd. DA Davidson reissued a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research report on Thursday, January 23rd. JPMorgan Chase & Co. reduced their price target on shares of Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday, January 16th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research report on Thursday, January 23rd. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $181.82.
Insider Activity at Procter & Gamble
In other news, insider Marc S. Pritchard sold 90,450 shares of Procter & Gamble stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the completion of the transaction, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. The trade was a 34.36 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary A. Coombe sold 35,000 shares of the firm’s stock in a transaction on Friday, February 28th. The stock was sold at an average price of $173.68, for a total value of $6,078,800.00. Following the completion of the sale, the chief executive officer now owns 22,051 shares of the company’s stock, valued at approximately $3,829,817.68. This represents a 61.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 143,450 shares of company stock valued at $23,988,008. 0.18% of the stock is owned by corporate insiders.
Procter & Gamble Trading Down 0.5 %
Procter & Gamble stock opened at $169.74 on Thursday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.76 and a quick ratio of 0.55. The firm’s 50 day moving average price is $169.07 and its 200-day moving average price is $169.27. The Procter & Gamble Company has a 1 year low of $153.52 and a 1 year high of $180.43. The stock has a market cap of $398.02 billion, a P/E ratio of 27.03, a PEG ratio of 3.76 and a beta of 0.41.
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The business had revenue of $21.88 billion for the quarter, compared to analysts’ expectations of $21.66 billion. During the same quarter in the previous year, the company earned $1.84 EPS. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, January 24th. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. Procter & Gamble’s dividend payout ratio (DPR) is 64.01%.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- Stock Average Calculator
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Buy P&G Now, Before It Sets A New All-Time High
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Health Care Stocks Explained: Why You Might Want to Invest
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.